Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Midodrine 2.5mg tablets
0207020Y0AAAEAE
|
Midodrine hydrochloride | Midodrine hydrochloride | Cardiovascular System | 30,810 |
|
Midodrine 5mg tablets
0207020Y0AAAFAF
|
Midodrine hydrochloride | Midodrine hydrochloride | Cardiovascular System | 26,529 |
|
Midodrine 10mg tablets
0207020Y0AAAGAG
|
Midodrine hydrochloride | Midodrine hydrochloride | Cardiovascular System | 3,928 |
|
Bramox 5mg tablets
0207020Y0BDABAF
|
Bramox | Midodrine hydrochloride | Cardiovascular System | 926 |
|
Bramox 2.5mg tablets
0207020Y0BDAAAE
|
Bramox | Midodrine hydrochloride | Cardiovascular System | 735 |
|
Bramox 10mg tablets
0207020Y0BDACAG
|
Bramox | Midodrine hydrochloride | Cardiovascular System | 72 |
|
Gutron 2.5mg tablets
0207020Y0BBAAAE
|
Gutron | Midodrine hydrochloride | Cardiovascular System | No data available |
|
Gutron 5mg tablets
0207020Y0BBABAF
|
Gutron | Midodrine hydrochloride | Cardiovascular System | No data available |
|
Midotense 2.5mg tablets
0207020Y0BEAAAE
|
Midotense | Midodrine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.